7
Views
9
CrossRef citations to date
0
Altmetric
Articles

Incidence of adequate ICD interventions in patients with hypertrophic cardiomyopathy supposed to be at high risk for sudden cardiac death

, , , , , & show all
Pages 521-525 | Received 26 May 2010, Accepted 21 Jun 2010, Published online: 23 May 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Pawel Rubis, Barbara Biernacka-Fijalkowska, Lusine Khachatryan, Aleksandra Karabinowska, Patrycja Faltyn, Ewa Dzwiecka, Sylwia Wisniowska-Smialek, Lidia Tomkiewcz-Pająk & Piotr Podolec. (2017) Comparison of two European models estimating risk of ­sudden cardiac death in hypertrophic cardiomyopathy. Acta Cardiologica 72:4, pages 446-452.
Read now
Christian Prinz, Martin Farr, Kai Thorsten Laser, Helmut Esdorn, Cornelia Piper, Dieter Horstkotte & Lothar Faber. (2013) Determining the role of fibrosis in hypertrophic cardiomyopathy. Expert Review of Cardiovascular Therapy 11:4, pages 495-504.
Read now

Articles from other publishers (7)

Barry J. Maron, Milind Y. Desai, Rick A. Nishimura, Paolo Spirito, Harry Rakowski, Jeffrey A. Towbin, Joseph A. Dearani, Ethan J. Rowin, Martin S. Maron & Mark V. Sherrid. (2022) Management of Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology 79:4, pages 390-414.
Crossref
Anastasia MironMyriam Lafreniere-RoulaChun-Po Steve FanKatey R. ArmstrongAndreea DragulescuTanya PapazCedric ManlhiotBeth KaufmanRyan J. ButtsLetizia GardinElizabeth A. StephensonTaylor S. HowardPete F. AzizSeshadri BalajiVirginie Beauséjour LadouceurLee N. BensonSteven D. ColanJustin GodownHeather T. HendersonJodie InglesAamir JeewaJohn L. JefferiesAshwin K. LalJacob MathewEmilie Jean-St-MichelMichelle MichelsStephanie J. NakanoIacopo OlivottoJohn J. ParentAlexandre C. PereiraChristopher SemsarianRobert D. WhitehillSamuel G. WittekindMark W. RussellJennifer ConwayMarc E. RichmondChet VillaRobert G. WeintraubJoseph W. RossanoPaul F. KantorCarolyn Y. HoSeema Mital. (2020) A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy. Circulation 142:3, pages 217-229.
Crossref
Barry J. MaronEthan J. RowinMartin S. Maron. (2019) Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy. Circulation Research 125:4, pages 370-378.
Crossref
Louise R.A. Olde Nordkamp, Pieter G. Postema, Reinoud E. Knops, Nynke van Dijk, Jacqueline Limpens, Arthur A.M. Wilde & Joris R. de Groot. (2016) Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications. Heart Rhythm 13:2, pages 443-454.
Crossref
Philippe Debonnaire, Joep Thijssen, Darryl P. Leong, Emer Joyce, Spyridon Katsanos, Georgette E. Hoogslag, Martin J. Schalij, Douwe E. Atsma, Jeroen J. Bax, Victoria Delgado & Nina Ajmone Marsan. (2014) Global longitudinal strain and left atrial volume index improve prediction of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy patients. The International Journal of Cardiovascular Imaging 30:3, pages 549-558.
Crossref
Barry J. Maron, Paolo Spirito, Michael J. Ackerman, Susan A. Casey, Christopher Semsarian, N.A. Mark EstesIIIIII, Kevin M. Shannon, Euan A. Ashley, Sharlene M. Day, Giuseppe Pacileo, Francesco Formisano, Emmanuela Devoto, Aristidis Anastasakis, J. Martijn Bos, Anna Woo, Camillo Autore, Robert H. Pass, Giuseppe Boriani, Ross F. Garberich, Adrian K. Almquist, Mark W. Russell, Luca Boni, Stuart Berger, Martin S. Maron & Mark S. Link. (2013) Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology 61:14, pages 1527-1535.
Crossref
Arend F.L. SchinkelPieter A. VriesendorpEric J.G. SijbrandsLuc J.L.M. JordaensFolkert J. ten CateMichelle Michels. (2012) Outcome and Complications After Implantable Cardioverter Defibrillator Therapy in Hypertrophic Cardiomyopathy. Circulation: Heart Failure 5:5, pages 552-559.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.